NO20052633L - Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases - Google Patents
Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseasesInfo
- Publication number
- NO20052633L NO20052633L NO20052633A NO20052633A NO20052633L NO 20052633 L NO20052633 L NO 20052633L NO 20052633 A NO20052633 A NO 20052633A NO 20052633 A NO20052633 A NO 20052633A NO 20052633 L NO20052633 L NO 20052633L
- Authority
- NO
- Norway
- Prior art keywords
- imaging
- cardiovascular diseases
- scavenger receptor
- receptor antagonists
- macrophage scavenger
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 4
- 108091005485 macrophage scavenger receptors Proteins 0.000 title abstract 2
- 102000014452 scavenger receptors Human genes 0.000 title abstract 2
- 238000003384 imaging method Methods 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 238000002059 diagnostic imaging Methods 0.000 abstract 4
- 239000012216 imaging agent Substances 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0228490.9A GB0228490D0 (en) | 2002-12-06 | 2002-12-06 | Novel imaging compounds |
| PCT/GB2003/005319 WO2004052357A1 (en) | 2002-12-06 | 2003-12-05 | Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052633D0 NO20052633D0 (no) | 2005-06-01 |
| NO20052633L true NO20052633L (no) | 2005-07-06 |
Family
ID=9949200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052633A NO20052633L (no) | 2002-12-06 | 2005-06-01 | Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060239915A1 (https=) |
| EP (1) | EP1567141A1 (https=) |
| JP (1) | JP2006514945A (https=) |
| CN (1) | CN1744890A (https=) |
| AU (1) | AU2003292384B2 (https=) |
| CA (1) | CA2508663A1 (https=) |
| GB (1) | GB0228490D0 (https=) |
| NO (1) | NO20052633L (https=) |
| RU (1) | RU2005116983A (https=) |
| WO (1) | WO2004052357A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7886497B2 (en) | 2003-12-02 | 2011-02-15 | Valinge Innovation Ab | Floorboard, system and method for forming a flooring, and a flooring formed thereof |
| GB0428020D0 (en) | 2004-12-22 | 2005-01-26 | Amersham Health As | Stabilisation of radiopharmaceutical precursors |
| WO2006077901A1 (ja) * | 2005-01-20 | 2006-07-27 | Shionogi & Co., Ltd. | Ctgf発現阻害剤 |
| MX2010005122A (es) * | 2007-11-07 | 2010-08-18 | Ge Healthcare Bv | Estabilizacion de radiofarmaceuticos. |
| US11725395B2 (en) | 2009-09-04 | 2023-08-15 | Välinge Innovation AB | Resilient floor |
| ES2985671T3 (es) | 2009-09-04 | 2024-11-06 | Vaelinge Innovation Ab | Suelo elástico |
| JP6105587B2 (ja) | 2011-08-29 | 2017-04-05 | セラロック、イノベーション、アクチボラグ | フロアパネル用機械式係止システム |
| EP3656944A1 (en) | 2013-03-25 | 2020-05-27 | Välinge Innovation AB | Floorboards provided with a mechanical locking system and a method to produce such a locking system |
| EP4140991B1 (en) * | 2018-06-01 | 2024-05-15 | Promega Corporation | Inhibitors of oplophorus luciferase-derived bioluminescent complexes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5820873A (en) * | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| WO2000078145A1 (en) * | 1999-06-24 | 2000-12-28 | Smithkline Beecham Corporation | Macrophage scavenger receptor antagonists |
| WO2001098264A1 (en) * | 2000-06-21 | 2001-12-27 | Smithkline Beecham Corporation | Macrophage scavenger receptor antagonists |
| AU2002254000A1 (en) * | 2001-02-23 | 2002-09-12 | Bristol-Myers Squibb Pharma Company | Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
-
2002
- 2002-12-06 GB GBGB0228490.9A patent/GB0228490D0/en not_active Ceased
-
2003
- 2003-12-05 CN CNA2003801095526A patent/CN1744890A/zh active Pending
- 2003-12-05 AU AU2003292384A patent/AU2003292384B2/en not_active Ceased
- 2003-12-05 WO PCT/GB2003/005319 patent/WO2004052357A1/en not_active Ceased
- 2003-12-05 JP JP2004558793A patent/JP2006514945A/ja active Pending
- 2003-12-05 EP EP03767961A patent/EP1567141A1/en not_active Withdrawn
- 2003-12-05 RU RU2005116983/15A patent/RU2005116983A/ru not_active Application Discontinuation
- 2003-12-05 US US10/537,103 patent/US20060239915A1/en not_active Abandoned
- 2003-12-05 CA CA002508663A patent/CA2508663A1/en not_active Abandoned
-
2005
- 2005-06-01 NO NO20052633A patent/NO20052633L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1744890A (zh) | 2006-03-08 |
| GB0228490D0 (en) | 2003-01-08 |
| NO20052633D0 (no) | 2005-06-01 |
| JP2006514945A (ja) | 2006-05-18 |
| WO2004052357A1 (en) | 2004-06-24 |
| US20060239915A1 (en) | 2006-10-26 |
| RU2005116983A (ru) | 2006-02-27 |
| AU2003292384A1 (en) | 2004-06-30 |
| CA2508663A1 (en) | 2004-06-24 |
| EP1567141A1 (en) | 2005-08-31 |
| AU2003292384B2 (en) | 2007-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
| NO20074895L (no) | Isoksazolin derivat og ny fremgangsmate for fremstilling derav | |
| NO20085338L (no) | Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav | |
| BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
| SV2008003074A (es) | Piridin[3,4-b] pirazinonas | |
| WO2007118963A3 (fr) | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations | |
| EA200900211A1 (ru) | Замещенные производные имидазолона, их получение и применение | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
| EP1933883A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS OF IGA- AND IGM-MEDICINED KIDNEY DISEASES | |
| NO20092584L (no) | Farmasoytiske sammensetninger og deres fremgangsmater for anvendelse | |
| NO20045281L (no) | Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer | |
| JO2984B1 (ar) | تركيب الجسم المضاد her2 | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| EA200700566A1 (ru) | Фармацевтические композиции, включающие леветирацетам, и способы их получения | |
| UA102236C2 (uk) | Похідні еритропоетин-міметичного пептиду та їх фармацевтичні солі, їх одержання і застосування | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| UY28922A1 (es) | Ligandos del receptor cb1 útiles en el tratamiento de dolor y/u otros síntomas o enfermedades relacionadas; compuestos farmacéuticos y su preparación. | |
| NO20064078L (no) | Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter | |
| ATE491446T1 (de) | Ligustilid zur behandlung von erkrankungen des zentralen nervensystems | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| SV2005002099A (es) | " nuevos compuestos " ref. pc 32096a | |
| ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
| NO20052633L (no) | Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |